CommentarySimple deliverable therapy needed for childhood leukaemia
References (8)
- et al.
Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin)
N Engl J Med
(1948) - et al.
Newly diagnosed childhood lymphoblastic leukemia: update on prognostic factors and treatment
Curr Opin Hematol
(2003) - et al.
Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)
Br J Haematol
(2000) Science, medicine and the future: Childhood leukaemia
BMJ
(2002)
There are more references available in the full text version of this article.
Cited by (20)
Global cancer surgery: Delivering safe, affordable, and timely cancer surgery
2015, The Lancet OncologyDoes aid reach the poor? Experiences of a childhood leukaemia outreach-programme
2009, European Journal of CancerCitation Excerpt :We tried to improve aid-assignment in our childhood leukaemia outreach-programme between paediatric–oncology departments in Indonesia (Dr. Sardjito Hospital, Yogyakarta) and The Netherlands (VU University Medical Centre, Amsterdam). The cure rate of childhood acute lymphoblastic leukaemia (ALL), the most common cancer in children, is as high as 80% in the developed countries and is frequently less than 35% in the developing nations.3–11 In a previous study,12 we found that the treatment results in Indonesia differed significantly between 164 children with different socio-economic backgrounds, even though the children were treated in the same hospital with the same protocol.
Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India
2017, Pediatric Blood and CancerPopulation Dynamics, Demographics and Disease Burden of Infants and Children across the World
2013, Pediatric Drug Development: Concepts and Applications
Copyright © 2003 Elsevier Ltd. All rights reserved.